TCTR20240715015已完成3 期
se of the oral sialogogue (Oryza tablet) in reducing drug-induced xerostomia in patients with overactive bladder or neurogenic bladder: randomized clinical study
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
Continuous daily use of Oryza tablet for 4 weeks reduced xerostomia symptoms and increased saliva production in patients suffering from neurologic bladder or overactive bladder who received antimuscarinic medications.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •Overactive bladder and neurogenic bladder patient who use anticholinergic drug with xerostomia symptoms
- •Age 18 year old or older
- •Informed consent was made
排除标准
- •Recently xerostomia symptoms within 3 months
- •History of head & neck radiation
- •Autoimmune disease
- •History of salivary gland surgery
- •Dental and oral infection
- •Uncooperative patient
- •History of drug allergy
研究者
相似试验
已完成
不适用
NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP TherapyXerostomiaNCT02107300Medical University of South Carolina32
已完成
不适用
Placebo-controlled randomized trial on the saliva secretion effect of interferential current stimulatioHealthy subjects and patients with xerostomiaJPRN-UMIN000013731Hyogo College of Medicine60
已完成
不适用
Efficacy Study of a Ginger and Cardamom Gelatin for Xerostomy in Terminally Ill PatientsSalivary Gland DiseasesMouth DiseasesXerostomiaNCT01915966Fundacio Salut i Envelliment UAB32
已完成
不适用
Beneficial Effects of Natural Products on Management of XerostomiaPost COVID-19 ConditionHypertensionDiabetes MellitusXerostomiaNCT06217614British University In Egypt28
Unknown
不适用
Malic Acid in Treatment of XerostomiaXerostomiaNCT04756986Hams Hamed Abdelrahman52